Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease

O-GlcNAcylation is the addition of β-D- N -acetylglucosamine to serine or threonine residues of nuclear and cytoplasmic proteins. O-linked N -acetylglucosamine (O-GlcNAc) was not discovered until the early 1980s and still remains difficult to detect and quantify. Nonetheless, O-GlcNAc is highly abun...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annual review of biochemistry 2011-01, Vol.80 (1), p.825-858
Hauptverfasser: Hart, Gerald W, Slawson, Chad, Ramirez-Correa, Genaro, Lagerlof, Olof
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 858
container_issue 1
container_start_page 825
container_title Annual review of biochemistry
container_volume 80
creator Hart, Gerald W
Slawson, Chad
Ramirez-Correa, Genaro
Lagerlof, Olof
description O-GlcNAcylation is the addition of β-D- N -acetylglucosamine to serine or threonine residues of nuclear and cytoplasmic proteins. O-linked N -acetylglucosamine (O-GlcNAc) was not discovered until the early 1980s and still remains difficult to detect and quantify. Nonetheless, O-GlcNAc is highly abundant and cycles on proteins with a timescale similar to protein phosphorylation. O-GlcNAc occurs in organisms ranging from some bacteria to protozoans and metazoans, including plants and nematodes up the evolutionary tree to man. O-GlcNAcylation is mostly on nuclear proteins, but it occurs in all intracellular compartments, including mitochondria. Recent glycomic analyses have shown that O-GlcNAcylation has surprisingly extensive cross talk with phosphorylation, where it serves as a nutrient stress sensor to modulate signaling, transcription, and cytoskeletal functions. Abnormal amounts of O-GlcNAcylation underlie the etiology of insulin resistance and glucose toxicity in diabetes, and this type of modification plays a direct role in neurodegenerative disease. Many oncogenic proteins and tumor suppressor proteins are also regulated by O-GlcNAcylation. Current data justify extensive efforts toward a better understanding of this invisible, yet abundant, modification. As tools for the study of O-GlcNAc become more facile and available, exponential growth in this area of research will eventually take place.
doi_str_mv 10.1146/annurev-biochem-060608-102511
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_21391816</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2387682551</sourcerecordid><originalsourceid>FETCH-LOGICAL-a657t-1909657fb78e101346fd6200e5374226b9cc9c3e81f70411281de8061d5cbb033</originalsourceid><addsrcrecordid>eNqVklFv0zAUhSMEYt3gL6AICbGHBXxtx0mQQOo6GEgTQ1B4tRz3tvVI7GInq_bvcUiYGA9IyA-2rr9z7GufJHkG5AUAFy-Vtb3H66w2Tm-xzYiIo8yA0BzgXjKDnOcZz0l1P5kRIkTGY-UgOQzhihDCKk4fJgcUWAUliFliF96FkC5V8z09xW6PaNPL7LzRH-f6plGdcTZVdpV-2rqw2zo_1V6ln12DITU2_WI2VjXGbk7SpVc2aG92A3LyS7fYemeNTs9MQBXwUfJgrZqAj6f5KPn67u1y8T67uDz_sJhfZErkRZdBRaq4WNdFiUCAcbFeCUoI5qzglIq60rrSDEtYF4QD0BJWWBIBq1zXNWHsKMlG37DHXV_LnTet8jfSKSPPzLe5dH4j-7aXUNICROTfjHyEW1xptJ1XzR3Z3R1rtnLjriWjFWfFYPB8MvDuR4-hk60JGptGWXR9kGVBOcsJ4ZE8_icZP7lksfmqiOjTv9Ar1_v42oMfp0BpQSL0eoT08JMe17e3BiKHyMgpMnKKjBwjI8fIRP2TP1u_Vf_OSAROR2DwUU10MrgP_3nKTwvJ2Mg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>874212270</pqid></control><display><type>article</type><title>Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease</title><source>Annual Reviews Complete A-Z List</source><source>MEDLINE</source><creator>Hart, Gerald W ; Slawson, Chad ; Ramirez-Correa, Genaro ; Lagerlof, Olof</creator><creatorcontrib>Hart, Gerald W ; Slawson, Chad ; Ramirez-Correa, Genaro ; Lagerlof, Olof</creatorcontrib><description>O-GlcNAcylation is the addition of β-D- N -acetylglucosamine to serine or threonine residues of nuclear and cytoplasmic proteins. O-linked N -acetylglucosamine (O-GlcNAc) was not discovered until the early 1980s and still remains difficult to detect and quantify. Nonetheless, O-GlcNAc is highly abundant and cycles on proteins with a timescale similar to protein phosphorylation. O-GlcNAc occurs in organisms ranging from some bacteria to protozoans and metazoans, including plants and nematodes up the evolutionary tree to man. O-GlcNAcylation is mostly on nuclear proteins, but it occurs in all intracellular compartments, including mitochondria. Recent glycomic analyses have shown that O-GlcNAcylation has surprisingly extensive cross talk with phosphorylation, where it serves as a nutrient stress sensor to modulate signaling, transcription, and cytoskeletal functions. Abnormal amounts of O-GlcNAcylation underlie the etiology of insulin resistance and glucose toxicity in diabetes, and this type of modification plays a direct role in neurodegenerative disease. Many oncogenic proteins and tumor suppressor proteins are also regulated by O-GlcNAcylation. Current data justify extensive efforts toward a better understanding of this invisible, yet abundant, modification. As tools for the study of O-GlcNAc become more facile and available, exponential growth in this area of research will eventually take place.</description><identifier>ISSN: 0066-4154</identifier><identifier>ISSN: 1545-4509</identifier><identifier>EISSN: 1545-4509</identifier><identifier>DOI: 10.1146/annurev-biochem-060608-102511</identifier><identifier>PMID: 21391816</identifier><identifier>CODEN: ARBOAW</identifier><language>eng</language><publisher>United States: Annual Reviews</publisher><subject>Acetylglucosamine - chemistry ; Acetylglucosamine - metabolism ; Alzheimer's disease ; Animals ; cancer ; Chronic Disease ; Chronic illnesses ; diabetes ; Diabetes Mellitus - physiopathology ; Glycosylation ; Humans ; Metazoa ; Models, Molecular ; Molecular Structure ; N-Acetylglucosaminyltransferases - metabolism ; Nematoda ; Neoplasms - physiopathology ; Neurodegenerative Diseases - physiopathology ; O-GlcNAc ; Phosphorylation ; Protein Conformation ; Proteins ; Signal transduction ; Signal Transduction - physiology ; Transcription, Genetic ; translation</subject><ispartof>Annual review of biochemistry, 2011-01, Vol.80 (1), p.825-858</ispartof><rights>Copyright © 2011 by Annual Reviews. All rights reserved 2011</rights><rights>Copyright Annual Reviews, Inc. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a657t-1909657fb78e101346fd6200e5374226b9cc9c3e81f70411281de8061d5cbb033</citedby><cites>FETCH-LOGICAL-a657t-1909657fb78e101346fd6200e5374226b9cc9c3e81f70411281de8061d5cbb033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.annualreviews.org/content/journals/10.1146/annurev-biochem-060608-102511?crawler=true&amp;mimetype=application/pdf$$EPDF$$P50$$Gannualreviews$$H</linktopdf><linktohtml>$$Uhttps://www.annualreviews.org/content/journals/10.1146/annurev-biochem-060608-102511$$EHTML$$P50$$Gannualreviews$$H</linktohtml><link.rule.ids>70,230,314,776,780,881,4168,27901,27902,77996,77997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21391816$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-182716$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Hart, Gerald W</creatorcontrib><creatorcontrib>Slawson, Chad</creatorcontrib><creatorcontrib>Ramirez-Correa, Genaro</creatorcontrib><creatorcontrib>Lagerlof, Olof</creatorcontrib><title>Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease</title><title>Annual review of biochemistry</title><addtitle>Annu Rev Biochem</addtitle><description>O-GlcNAcylation is the addition of β-D- N -acetylglucosamine to serine or threonine residues of nuclear and cytoplasmic proteins. O-linked N -acetylglucosamine (O-GlcNAc) was not discovered until the early 1980s and still remains difficult to detect and quantify. Nonetheless, O-GlcNAc is highly abundant and cycles on proteins with a timescale similar to protein phosphorylation. O-GlcNAc occurs in organisms ranging from some bacteria to protozoans and metazoans, including plants and nematodes up the evolutionary tree to man. O-GlcNAcylation is mostly on nuclear proteins, but it occurs in all intracellular compartments, including mitochondria. Recent glycomic analyses have shown that O-GlcNAcylation has surprisingly extensive cross talk with phosphorylation, where it serves as a nutrient stress sensor to modulate signaling, transcription, and cytoskeletal functions. Abnormal amounts of O-GlcNAcylation underlie the etiology of insulin resistance and glucose toxicity in diabetes, and this type of modification plays a direct role in neurodegenerative disease. Many oncogenic proteins and tumor suppressor proteins are also regulated by O-GlcNAcylation. Current data justify extensive efforts toward a better understanding of this invisible, yet abundant, modification. As tools for the study of O-GlcNAc become more facile and available, exponential growth in this area of research will eventually take place.</description><subject>Acetylglucosamine - chemistry</subject><subject>Acetylglucosamine - metabolism</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>cancer</subject><subject>Chronic Disease</subject><subject>Chronic illnesses</subject><subject>diabetes</subject><subject>Diabetes Mellitus - physiopathology</subject><subject>Glycosylation</subject><subject>Humans</subject><subject>Metazoa</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>N-Acetylglucosaminyltransferases - metabolism</subject><subject>Nematoda</subject><subject>Neoplasms - physiopathology</subject><subject>Neurodegenerative Diseases - physiopathology</subject><subject>O-GlcNAc</subject><subject>Phosphorylation</subject><subject>Protein Conformation</subject><subject>Proteins</subject><subject>Signal transduction</subject><subject>Signal Transduction - physiology</subject><subject>Transcription, Genetic</subject><subject>translation</subject><issn>0066-4154</issn><issn>1545-4509</issn><issn>1545-4509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVklFv0zAUhSMEYt3gL6AICbGHBXxtx0mQQOo6GEgTQ1B4tRz3tvVI7GInq_bvcUiYGA9IyA-2rr9z7GufJHkG5AUAFy-Vtb3H66w2Tm-xzYiIo8yA0BzgXjKDnOcZz0l1P5kRIkTGY-UgOQzhihDCKk4fJgcUWAUliFliF96FkC5V8z09xW6PaNPL7LzRH-f6plGdcTZVdpV-2rqw2zo_1V6ln12DITU2_WI2VjXGbk7SpVc2aG92A3LyS7fYemeNTs9MQBXwUfJgrZqAj6f5KPn67u1y8T67uDz_sJhfZErkRZdBRaq4WNdFiUCAcbFeCUoI5qzglIq60rrSDEtYF4QD0BJWWBIBq1zXNWHsKMlG37DHXV_LnTet8jfSKSPPzLe5dH4j-7aXUNICROTfjHyEW1xptJ1XzR3Z3R1rtnLjriWjFWfFYPB8MvDuR4-hk60JGptGWXR9kGVBOcsJ4ZE8_icZP7lksfmqiOjTv9Ar1_v42oMfp0BpQSL0eoT08JMe17e3BiKHyMgpMnKKjBwjI8fIRP2TP1u_Vf_OSAROR2DwUU10MrgP_3nKTwvJ2Mg</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Hart, Gerald W</creator><creator>Slawson, Chad</creator><creator>Ramirez-Correa, Genaro</creator><creator>Lagerlof, Olof</creator><general>Annual Reviews</general><general>Annual Reviews, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D93</scope></search><sort><creationdate>20110101</creationdate><title>Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease</title><author>Hart, Gerald W ; Slawson, Chad ; Ramirez-Correa, Genaro ; Lagerlof, Olof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a657t-1909657fb78e101346fd6200e5374226b9cc9c3e81f70411281de8061d5cbb033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acetylglucosamine - chemistry</topic><topic>Acetylglucosamine - metabolism</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>cancer</topic><topic>Chronic Disease</topic><topic>Chronic illnesses</topic><topic>diabetes</topic><topic>Diabetes Mellitus - physiopathology</topic><topic>Glycosylation</topic><topic>Humans</topic><topic>Metazoa</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>N-Acetylglucosaminyltransferases - metabolism</topic><topic>Nematoda</topic><topic>Neoplasms - physiopathology</topic><topic>Neurodegenerative Diseases - physiopathology</topic><topic>O-GlcNAc</topic><topic>Phosphorylation</topic><topic>Protein Conformation</topic><topic>Proteins</topic><topic>Signal transduction</topic><topic>Signal Transduction - physiology</topic><topic>Transcription, Genetic</topic><topic>translation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hart, Gerald W</creatorcontrib><creatorcontrib>Slawson, Chad</creatorcontrib><creatorcontrib>Ramirez-Correa, Genaro</creatorcontrib><creatorcontrib>Lagerlof, Olof</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Umeå universitet</collection><jtitle>Annual review of biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hart, Gerald W</au><au>Slawson, Chad</au><au>Ramirez-Correa, Genaro</au><au>Lagerlof, Olof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease</atitle><jtitle>Annual review of biochemistry</jtitle><addtitle>Annu Rev Biochem</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>80</volume><issue>1</issue><spage>825</spage><epage>858</epage><pages>825-858</pages><issn>0066-4154</issn><issn>1545-4509</issn><eissn>1545-4509</eissn><coden>ARBOAW</coden><abstract>O-GlcNAcylation is the addition of β-D- N -acetylglucosamine to serine or threonine residues of nuclear and cytoplasmic proteins. O-linked N -acetylglucosamine (O-GlcNAc) was not discovered until the early 1980s and still remains difficult to detect and quantify. Nonetheless, O-GlcNAc is highly abundant and cycles on proteins with a timescale similar to protein phosphorylation. O-GlcNAc occurs in organisms ranging from some bacteria to protozoans and metazoans, including plants and nematodes up the evolutionary tree to man. O-GlcNAcylation is mostly on nuclear proteins, but it occurs in all intracellular compartments, including mitochondria. Recent glycomic analyses have shown that O-GlcNAcylation has surprisingly extensive cross talk with phosphorylation, where it serves as a nutrient stress sensor to modulate signaling, transcription, and cytoskeletal functions. Abnormal amounts of O-GlcNAcylation underlie the etiology of insulin resistance and glucose toxicity in diabetes, and this type of modification plays a direct role in neurodegenerative disease. Many oncogenic proteins and tumor suppressor proteins are also regulated by O-GlcNAcylation. Current data justify extensive efforts toward a better understanding of this invisible, yet abundant, modification. As tools for the study of O-GlcNAc become more facile and available, exponential growth in this area of research will eventually take place.</abstract><cop>United States</cop><pub>Annual Reviews</pub><pmid>21391816</pmid><doi>10.1146/annurev-biochem-060608-102511</doi><tpages>34</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4154
ispartof Annual review of biochemistry, 2011-01, Vol.80 (1), p.825-858
issn 0066-4154
1545-4509
1545-4509
language eng
recordid cdi_pubmed_primary_21391816
source Annual Reviews Complete A-Z List; MEDLINE
subjects Acetylglucosamine - chemistry
Acetylglucosamine - metabolism
Alzheimer's disease
Animals
cancer
Chronic Disease
Chronic illnesses
diabetes
Diabetes Mellitus - physiopathology
Glycosylation
Humans
Metazoa
Models, Molecular
Molecular Structure
N-Acetylglucosaminyltransferases - metabolism
Nematoda
Neoplasms - physiopathology
Neurodegenerative Diseases - physiopathology
O-GlcNAc
Phosphorylation
Protein Conformation
Proteins
Signal transduction
Signal Transduction - physiology
Transcription, Genetic
translation
title Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T10%3A11%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cross%20Talk%20Between%20O-GlcNAcylation%20and%20Phosphorylation:%20Roles%20in%20Signaling,%20Transcription,%20and%20Chronic%20Disease&rft.jtitle=Annual%20review%20of%20biochemistry&rft.au=Hart,%20Gerald%20W&rft.date=2011-01-01&rft.volume=80&rft.issue=1&rft.spage=825&rft.epage=858&rft.pages=825-858&rft.issn=0066-4154&rft.eissn=1545-4509&rft.coden=ARBOAW&rft_id=info:doi/10.1146/annurev-biochem-060608-102511&rft_dat=%3Cproquest_pubme%3E2387682551%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=874212270&rft_id=info:pmid/21391816&rfr_iscdi=true